Factors Affecting the Colistin Nephrotoxicity: Advanced Age and/or Other Factors?

Basit Öğe Kaydı
dc.authoridKayabas, Uner/0000-0002-5323-0796
dc.contributor.authorGulen, Tugba Arslan
dc.contributor.authorImre, Ayfer
dc.contributor.authorKayabas, Uner
dc.date.accessioned2024-11-07T13:25:18Z
dc.date.available2024-11-07T13:25:18Z
dc.date.issued2022
dc.departmentNiğde Ömer Halisdemir Üniversitesi
dc.description.abstractIntroduction: The population is aging, and older adults comprise most patients in the intensive care units. Colistin (COL) has been re-introduced to treat increasingly common resistant Gram-negative bacterial infections. Our study aims to investigate the factors affecting COL nephrotoxicity in a general population and geriatric age group. Materials and Methods: This retrospective study included 170 patients, a total of 116 (68.2%) of whom were in the geriatric group (age >= 65). Acute renal failure was evaluated using the RIFLE score. Factors associated with COL nephrotoxicity were described firstly in a general population and then in the geriatric group patients. Results: Advanced age [Odds ratio (OR): 1.043; 95% confidence interval (CI): 1.018-1.068; p=0.001] and initial serum creatinine level (OR: 23.122; 95 % CI: 3.123-171.217; p=0.002) were found to be the independent risk factors associated with nephrotoxicity. In the evaluation of the geriatric population based on nephrotoxicity, the initial serum urea and creatinine levels, and overall mortality rates were found to be statistically significantly higher in the group with nephrotoxicity (p<0.05). Initial serum creatinine level (OR: 22.48; 95 % CI: 2.835-178.426; p=0.003) and concomitant nephrotoxic agent use (OR: 2.516; 95 % CI: 1.275-4.963; p=0.008) were independent risk factors associated with nephrotoxicity in geriatric patients. Conclusion: Advanced age was found to be a risk factor for COL nephrotoxicity. Closed observation should be done especially in the geriatric patients who have initial serum creatinine levels close to the upper limit, concomitant use of the nephrotoxic drugs should be avoided, and if possible, evaluation should be made in terms of non-COL treatment options in these patients.
dc.identifier.doi10.4274/mjima.galenos.2022.2021.13
dc.identifier.issn2147-673X
dc.identifier.scopus2-s2.0-85127867215
dc.identifier.scopusqualityQ4
dc.identifier.urihttps://doi.org/10.4274/mjima.galenos.2022.2021.13
dc.identifier.urihttps://hdl.handle.net/11480/14635
dc.identifier.volume11
dc.identifier.wosWOS:000778571300001
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.language.isoen
dc.publisherGalenos Yayincilik
dc.relation.ispartofMediterranean Journal of Infection Microbes and Antimicrobials
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_20241106
dc.subjectColistin
dc.subjectnephrotoxicity
dc.subjectgeriatric patient
dc.subjectintensive care unit
dc.titleFactors Affecting the Colistin Nephrotoxicity: Advanced Age and/or Other Factors?
dc.title.alternativeKolistin Nefrotoksisitesini Etkileyen Faktorler: Ileri Yas mi, Diger Faktorler mi?
dc.typeArticle

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu